Sultan Alghadeer


No study was conducted to evaluate the efficacy of particular oral magnesium supplement over another in preventing migraine. Different magnesium supplements have different oral absorption and bioavailability. The objective was to identify the efficacy of different oral magnesium supplements in migraine prophylaxis. A literature review using MEDLINE, Scopus, Cochrane library, and EMBASE was conducted during the period from November 1, 2015 until December 30, 2015. Keywords included migraine, prophylaxis, and magnesium. Magnesium citrate was used as single oral migraine prophylactic supplement in most of the published trials. Migraine attack frequency and intensity were significantly lower in magnesium citrate group compared to placebo with 41.6-64% and 43-59% reduction in migraine attack frequency and severity frequently. Magnesium oxide was used in combination with magnesium citrate in 2 randomized clinical trials (RCTs), and used alone in one RCT in adults and children. No different in migraine frequency or severity between Mg-oxide and placebo in RCT conducted in children while Only Mg-oxide containing groups showed significant reduction in migraine days when compared to control (p<0.006) in RCT conducted in adults.  Magnesium chloride had never introduced as migraine prophylactic agent in clinical trials. Magnesium citrate seems to be the preferred oral magnesium supplement for migraine prevention; however, further studies comparing the efficacy of different oral magnesium supplements are needed.


magnesium; migraine; prophylaxis; efficacy; oral supplements

Full Text:

PDF (174-182)


Sun-Edelstein C, Mauskop A. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother. 2009; 9(3):369-379.

Bianchi A, Salomone S, Caraci F, Pizza V, Bernardini R, D’Amato CC. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam Horm. 2004; 69:297-312.

Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5(1):24-27.

Guerrera MP, Volpe SL, Mao JJ. Therapeutic uses of magnesium. Am Fam Physician. 2009; 80(2):157-162.

Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 1991; 31(5):298-301.

Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia an Int J headache. 1996; 16(4):257-263.

Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study. Cephalalgia. 1996; 16(6):436-440.

Demirkaya S, Dora B, Topcuoglu MA, Vural O, U HU. A comparative study of magnesium, flunarizine and amitriptyline in the prophylaxis of migraine. J Headache Pain. 2001; 1(2000):179-186.

Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: A randomized, double-blind, placebo-controlled trial. Headache. 2003; 43(6):601-610.

Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: A randomized trial. Headache. 2004; 44:885-890.

Köseoglu E, Talaslioglu A, Gönül AS, Kula M. The effects of magnesium prophylaxis in migraine without aura. Magnes Res. 2008; 21(2):101-108.

Tarighat Esfanjani A, Mahdavi R, Ebrahimi Mameghani M, Talebi M, Nikniaz Z, Safaiyan A. The Effects of Magnesium, l-Carnitine, and Concurrent Magnesium–l-Carnitine Supplementation in Migraine Prophylaxis. Biol Trace Elem Res. 2012; 150(1-3):42-48.

Gaul C, Diener H-C, Danesch U. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain. 2015; 16(1):32.

Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003; 16(3):183-191.

Shechter M, Saad T, Shechter A, Koren-Morag N, Silver BB, Matetzky S. Comparison of magnesium status using X-ray dispersion analysis following magnesium oxide and magnesium citrate treatment of healthy subjects. Magnes Res. 2012; 25(1):28-39.

Taubert K. [Magnesium in migraine. Results of a multicenter pilot study]. Fortschr Med. 1994; 112(24):328-330.

Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med. 2006; 23(10):1050-1056.

Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnes Res. 2001; 14(4):257-262.

Guerrero-Romero F, Rodríguez-Morán M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hy pertens. 2009; 23(4):245-251.

Shafique M, Misbah-ul-Ain, Ashraf M. Role of magnesium in the management of hypertension. J Pak Med Assoc. 1993; 43(4):77-78.

Hui ACF, Boet R, Cheng C a Y. Canadian Journal of Neurological Sciences. Spontaneous extra-cranial Vertebr artery dissection. 2003; 30:150-151.

Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults. Neurology. 2012; 78(17):1337-1345.



  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:

analytics View My Stats